400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Protein Tyrosine Kinase/RTK / MERTK & FGFR / MRX-2843
CAS No.: 1429882-07-4
Synonyms: UNC2371;UNC-2371A
MRX-2843 is an orally available small-molecule inhibitor of both MERTK and FLT3.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT03510104 | Advanced Cancer ... more >> Metastatic Cancer Neoplasms Neoplasm Metastasis Neoplastic Processes Pathologic Processes Collapse << | Phase 1 | Recruiting | November 2019 | United States, Georgia ... more >> Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Donald Harvey Principal Investigator: Donald Harvey United States, North Carolina Lineberger Comprehensive Cancer Center Recruiting Chapel Hill, North Carolina, United States, 27514 Contact: Elizabeth C Dees Principal Investigator: Elizabeth C Dees Collapse << |
实验方案
技术信息
CAS号 | 1429882-07-4 | 储存条件 |
|
|
分子式 | C29H40N6O | 运输 | 蓝冰 | |
分子量 | 488.67 | 别名 | UNC2371;UNC-2371A |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT03510104 | Advanced Cancer ... more >> Metastatic Cancer Neoplasms Neoplasm Metastasis Neoplastic Processes Pathologic Processes Collapse << | Phase 1 | Recruiting | November 2019 | United States, Georgia ... more >> Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Donald Harvey Principal Investigator: Donald Harvey United States, North Carolina Lineberger Comprehensive Cancer Center Recruiting Chapel Hill, North Carolina, United States, 27514 Contact: Elizabeth C Dees Principal Investigator: Elizabeth C Dees Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网